Cargando…
Prostaglandin E2 (PGE2) and Roflumilast Involvement in IPF Progression
The ECM propagates processes in idiopathic pulmonary fibrosis (IPF), leading to progressive lung scarring. We established an IPF-conditioned matrix (IPF-CM) system as a platform for testing drug candidates. Here, we tested the involvement of a PGE2 and PDE4 inhibitor, Roflumilast, in the IPF-CM syst...
Autores principales: | Moshkovitz, Noa, Epstein Shochet, Gali, Shitrit, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418473/ https://www.ncbi.nlm.nih.gov/pubmed/37569768 http://dx.doi.org/10.3390/ijms241512393 |
Ejemplares similares
-
MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)
por: Epstein Shochet, Gali, et al.
Publicado: (2021) -
TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling
por: Epstein Shochet, Gali, et al.
Publicado: (2020) -
Fibroblast paracrine TNF-α signaling elevates integrin A5 expression in idiopathic pulmonary fibrosis (IPF)
por: Epstein Shochet, Gali, et al.
Publicado: (2017) -
Integrin alpha-5 silencing leads to myofibroblastic differentiation in IPF-derived human lung fibroblasts
por: Shochet, Gali Epstein, et al.
Publicado: (2020) -
Mammalian oocytes are targets for prostaglandin E2 (PGE2) action
por: Duffy, Diane M, et al.
Publicado: (2010)